These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
|
|||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
|
|
|
|
|
|||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
|
Registrant’s telephone number, including area code:
|
|
|
||||||||||||
| Not Applicable | ||
| (Former name, former address and former fiscal year, if changed since last report) | ||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
|
|
|
|
||||||||||||
|
|
x | Accelerated filer |
¨
|
||||||||
| Non-accelerated filer |
¨
|
Smaller reporting company |
|
||||||||
| Emerging growth company |
|
||||||||||
| Class A Common Stock |
Shares outstanding as of September 3, 2025
|
|||||||
| $0.01 Par Value |
|
|||||||
| Item 1. | ||||||||
| Item 2. | ||||||||
| Item 3. | ||||||||
| Item 4. | ||||||||
| Item 1. | ||||||||
| Item 1A. | ||||||||
| Item 2. | ||||||||
| Item 5. | ||||||||
| Item 6. | ||||||||
| Abercrombie & Fitch Co. |
2
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Cost of sales, exclusive of depreciation and amortization |
|
|
|
|
|||||||||||||||||||||||||
| Selling expense |
|
|
|
|
|||||||||||||||||||||||||
| General and administrative expense |
|
|
|
|
|||||||||||||||||||||||||
| Other operating (income) loss, net |
(
|
(
|
|
(
|
|||||||||||||||||||||||||
| Operating income |
|
|
|
|
|||||||||||||||||||||||||
| Interest expense |
|
|
|
|
|||||||||||||||||||||||||
| Interest income |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||
| Interest income, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||
| Income before income taxes |
|
|
|
|
|||||||||||||||||||||||||
| Income tax expense |
|
|
|
|
|||||||||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||||||||
| Less: Net income attributable to noncontrolling interests |
|
|
|
|
|||||||||||||||||||||||||
| Net income attributable to A&F | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Net income per share attributable to A&F | |||||||||||||||||||||||||||||
| Basic | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Diluted | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Weighted-average shares outstanding | |||||||||||||||||||||||||||||
| Basic |
|
|
|
|
|||||||||||||||||||||||||
| Diluted |
|
|
|
|
|||||||||||||||||||||||||
| Other comprehensive income | |||||||||||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Derivative financial instruments, net of tax |
|
(
|
(
|
(
|
|||||||||||||||||||||||||
| Other comprehensive income |
|
|
|
|
|||||||||||||||||||||||||
| Comprehensive income |
|
|
|
|
|||||||||||||||||||||||||
| Less: Comprehensive income attributable to noncontrolling interests |
|
|
|
|
|||||||||||||||||||||||||
| Comprehensive income attributable to A&F | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Abercrombie & Fitch Co. |
3
|
2025 2Q Form 10-Q
|
||||||
| August 2, 2025 | February 1, 2025 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and equivalents | $ |
|
$ |
|
|||||||
|
Marketable securities
|
|
|
|||||||||
| Receivables |
|
|
|||||||||
| Inventories |
|
|
|||||||||
| Other current assets |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
| Property and equipment, net |
|
|
|||||||||
| Operating lease right-of-use assets |
|
|
|||||||||
| Other assets |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
| Liabilities and stockholders’ equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ |
|
$ |
|
|||||||
| Accrued expenses |
|
|
|||||||||
| Short-term portion of operating lease liabilities |
|
|
|||||||||
| Income taxes payable |
|
|
|||||||||
| Total current liabilities |
|
|
|||||||||
| Long-term liabilities: | |||||||||||
| Long-term portion of operating lease liabilities |
|
|
|||||||||
| Other liabilities |
|
|
|||||||||
| Total long-term liabilities |
|
|
|||||||||
| Stockholders’ equity | |||||||||||
|
Class A Common Stock: $
|
|
|
|||||||||
| Paid-in capital |
|
|
|||||||||
| Retained earnings |
|
|
|||||||||
| Accumulated other comprehensive loss, net of tax (“AOCL”) |
(
|
(
|
|||||||||
|
Treasury stock, at average cost:
|
(
|
(
|
|||||||||
| Total Abercrombie & Fitch Co. stockholders’ equity |
|
|
|||||||||
| Noncontrolling interests |
|
|
|||||||||
| Total stockholders’ equity |
|
|
|||||||||
| Total liabilities and stockholders’ equity | $ |
|
$ |
|
|||||||
| Abercrombie & Fitch Co. |
4
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended August 2, 2025 | |||||||||||||||||||||||||||||
| Common Stock |
Paid-in
capital |
Non-controlling interests |
Retained
earnings |
AOCL | Treasury stock |
Total
stockholders’ equity |
|||||||||||||||||||||||
|
Shares
outstanding |
Par
value |
Shares |
At average
cost |
||||||||||||||||||||||||||
| Balance, May 3, 2025 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||
| Net income | — | — | — |
|
|
— | — | — |
|
||||||||||||||||||||
|
Purchase of Common Stock
(1)
|
(
|
— | — | — | — | — |
|
(
|
(
|
||||||||||||||||||||
| Share-based compensation issuances and exercises |
|
— |
(
|
— |
(
|
— |
(
|
|
(
|
||||||||||||||||||||
| Share-based compensation expense | — | — |
|
— | — | — | — | — |
|
||||||||||||||||||||
| Derivative financial instruments, net of tax | — | — | — | — | — |
|
— | — |
|
||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | — | — | — | — | — |
|
— | — |
|
||||||||||||||||||||
|
Distribution to noncontrolling interests, net
|
— | — | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||
| Ending balance at August 2, 2025 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||
| Thirteen Weeks Ended August 3, 2024 | |||||||||||||||||||||||||||||
| Common Stock |
Paid-in
capital |
Non-controlling interests |
Retained
earnings |
AOCL | Treasury stock |
Total
stockholders’ equity |
|||||||||||||||||||||||
|
Shares
outstanding |
Par
value |
Shares |
At average
cost |
||||||||||||||||||||||||||
| Balance, May 4, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||
| Net income | — | — | — |
|
|
— | — | — |
|
||||||||||||||||||||
| Purchase of Common Stock |
(
|
— | — | — | — | — |
|
(
|
(
|
||||||||||||||||||||
| Share-based compensation issuances and exercises |
|
— |
(
|
— |
(
|
— |
(
|
|
(
|
||||||||||||||||||||
| Share-based compensation expense | — | — |
|
— | — | — | — | — |
|
||||||||||||||||||||
| Derivative financial instruments, net of tax | — | — | — | — | — |
(
|
— | — |
(
|
||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | — | — | — | — | — |
|
— | — |
|
||||||||||||||||||||
|
Contribution to noncontrolling interests, net
|
— | — | — |
|
— | — | — | — |
|
||||||||||||||||||||
| Ending balance at August 3, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||
|
(1)
Includes commissions and excise tax on share repurchases
|
|||||||||||||||||||||||||||||
| Abercrombie & Fitch Co. |
5
|
2025 2Q Form 10-Q
|
||||||
| Twenty-Six Weeks Ended August 2, 2025 | |||||||||||||||||||||||||||||
| Common Stock |
Paid-in
capital |
Non-controlling interests |
Retained
earnings |
AOCL | Treasury stock |
Total
stockholders’ equity |
|||||||||||||||||||||||
|
Shares
outstanding |
Par
value |
Shares |
At average
cost |
||||||||||||||||||||||||||
| Balance, February 1, 2025 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||
| Net income | — | — | — |
|
|
— | — | — |
|
||||||||||||||||||||
|
Purchase of Common Stock
(1)
|
(
|
— | — | — | — | — |
|
(
|
(
|
||||||||||||||||||||
| Share-based compensation issuances and exercises |
|
— |
(
|
— |
(
|
— |
(
|
|
(
|
||||||||||||||||||||
| Share-based compensation expense | — | — |
|
— | — | — | — | — |
|
||||||||||||||||||||
| Derivative financial instruments, net of tax | — | — | — | — | — |
(
|
— | — |
(
|
||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | — | — | — | — | — |
|
— | — |
|
||||||||||||||||||||
|
Distribution to noncontrolling interests, net
|
— | — | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||
| Ending balance at August 2, 2025 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||
| Twenty-Six Weeks Ended August 3, 2024 | |||||||||||||||||||||||||||||
| Common Stock |
Paid-in
capital |
Non-controlling interests |
Retained
earnings |
AOCL | Treasury stock |
Total
stockholders’ equity |
|||||||||||||||||||||||
|
Shares
outstanding |
Par
value |
Shares |
At average
cost |
||||||||||||||||||||||||||
| Balance, February 3, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||
| Net income | — | — | — |
|
|
— | — | — |
|
||||||||||||||||||||
| Purchase of Common Stock |
(
|
— | — | — | — | — |
|
(
|
(
|
||||||||||||||||||||
| Share-based compensation issuances and exercises |
|
— |
(
|
— |
(
|
— |
(
|
(
|
(
|
||||||||||||||||||||
| Share-based compensation expense | — | — |
|
— | — | — | — | — |
|
||||||||||||||||||||
| Derivative financial instruments, net of tax | — | — | — | — | — |
(
|
— | — |
(
|
||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | — | — | — | — | — |
|
— | — |
|
||||||||||||||||||||
|
Distribution to noncontrolling interests, net
|
— | — | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||
| Ending balance at August 3, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||
|
(1)
Includes commissions and excise tax on share repurchases
|
|||||||||||||||||||||||||||||
| Abercrombie & Fitch Co. |
6
|
2025 2Q Form 10-Q
|
||||||
| Twenty-Six Weeks Ended | |||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||
| Operating activities | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|||||||||||
| Depreciation and amortization |
|
|
|||||||||
| Amortization of capitalized cloud computing arrangement implementation costs |
|
|
|||||||||
| Asset impairment |
|
|
|||||||||
| Loss on disposal |
|
|
|||||||||
| Provision for (benefit from) deferred income taxes |
|
(
|
|||||||||
| Share-based compensation |
|
|
|||||||||
| Loss on extinguishment of debt |
|
|
|||||||||
| Changes in assets and liabilities: | |||||||||||
| Inventories |
(
|
(
|
|||||||||
| Accounts payable and accrued expenses |
(
|
|
|||||||||
| Operating lease right-of-use assets and liabilities |
|
(
|
|||||||||
| Income taxes |
(
|
(
|
|||||||||
| Other assets |
(
|
(
|
|||||||||
| Other liabilities |
(
|
|
|||||||||
| Net cash provided by operating activities |
|
|
|||||||||
| Investing activities | |||||||||||
|
Purchases of marketable securities
|
|
(
|
|||||||||
|
Proceeds from maturities of marketable securities
|
|
|
|||||||||
| Purchases of property and equipment |
(
|
(
|
|||||||||
| Net cash used for investing activities |
(
|
(
|
|||||||||
| Financing activities | |||||||||||
|
Repayment/redemption of senior secured notes
|
|
(
|
|||||||||
| Payment of debt modification costs and fees |
|
(
|
|||||||||
| Purchases of Common Stock |
(
|
(
|
|||||||||
|
Acquisition of Common Stock for tax withholding obligations
|
(
|
(
|
|||||||||
| Other financing activities |
(
|
(
|
|||||||||
| Net cash used for financing activities |
(
|
(
|
|||||||||
| Effect of foreign currency exchange rates on cash |
|
|
|||||||||
| Net decrease in cash and equivalents, and restricted cash and equivalents |
(
|
(
|
|||||||||
| Cash and equivalents, and restricted cash and equivalents, beginning of period |
|
|
|||||||||
| Cash and equivalents, and restricted cash and equivalents, end of period | $ |
|
$ |
|
|||||||
| Supplemental information related to non-cash activities | |||||||||||
|
Purchases of property and equipment accrued in accounts payable
|
$ |
|
$ |
|
|||||||
|
Excise tax liability accrued on share repurchases
|
|
|
|||||||||
| Operating lease right-of-use assets additions, net of terminations, impairments and other reductions |
|
|
|||||||||
| Supplemental information related to cash activities | |||||||||||
| Cash paid for interest |
|
|
|||||||||
| Cash paid for income taxes |
|
|
|||||||||
|
Cash paid for excise tax on share repurchases
|
|
|
|||||||||
| Cash received from income tax refunds |
|
|
|||||||||
|
Cash paid for amounts included in measurement of operating lease liabilities
|
|
|
|||||||||
| Abercrombie & Fitch Co. |
7
|
2025 2Q Form 10-Q
|
||||||
| Page No. | ||||||||
|
Note 1.
|
||||||||
|
Note 2.
|
||||||||
|
Note 3.
|
||||||||
|
Note 4.
|
||||||||
|
Note 5.
|
||||||||
|
Note 6.
|
||||||||
|
Note 7.
|
||||||||
|
Note 8.
|
||||||||
|
Note 9.
|
||||||||
|
Note 10.
|
||||||||
|
Note 11.
|
||||||||
|
Note 12.
|
||||||||
|
Note 13.
|
||||||||
|
Note 14.
|
||||||||
|
Note 15.
|
||||||||
| Abercrombie & Fitch Co. |
8
|
2025 2Q Form 10-Q
|
||||||
| Fiscal year | Year ended/ending | Number of weeks | ||||||||||||
| Fiscal 2024 | February 1, 2025 | 52 | ||||||||||||
| Fiscal 2025 | January 31, 2026 | 52 | ||||||||||||
| Fiscal 2026 | January 30, 2027 | 52 | ||||||||||||
| Abercrombie & Fitch Co. |
9
|
2025 2Q Form 10-Q
|
||||||
| Accounting Standards Update (ASU) | Description | Effect on the financial statements or other significant matters | ||||||||||||||||||
|
ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures
|
The update requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The update is effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively.
|
Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company’s consolidated financial statements.
|
||||||||||||||||||
|
ASU 2024-03 - Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses
ASU 2025-01 - Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date
|
The update requires a disaggregated disclosure of income statement expenses. The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The update is effective for fiscal years beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted.
|
Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company’s consolidated financial statements.
|
||||||||||||||||||
| (in thousands) | Location | August 2, 2025 | February 1, 2025 | August 3, 2024 | February 3, 2024 | ||||||||||||||||||||||||
| Cash and equivalents | Cash and equivalents | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
|
Restricted cash and equivalents
|
Other assets |
|
|
|
|
||||||||||||||||||||||||
| Cash and equivalents and restricted cash and equivalents | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Abercrombie & Fitch Co. |
10
|
2025 2Q Form 10-Q
|
||||||
| (in thousands) | August 2, 2025 | February 1, 2025 | August 3, 2024 | February 3, 2024 | |||||||||||||||||||
|
Gift card liability
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Loyalty programs liability |
|
|
|
|
|||||||||||||||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | August 2, 2025 | August 3, 2024 | |||||||||||||||||||
| Revenue associated with gift card redemptions and gift card breakage | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs |
|
|
|
|
|||||||||||||||||||
| Abercrombie & Fitch Co. |
11
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | August 2, 2025 | August 3, 2024 | |||||||||||||||||||
| Shares of Common Stock issued |
|
|
|
|
|||||||||||||||||||
| Weighted-average treasury shares |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Weighted-average — basic shares |
|
|
|
|
|||||||||||||||||||
| Dilutive effect of share-based compensation awards |
|
|
|
|
|||||||||||||||||||
| Weighted-average — diluted shares |
|
|
|
|
|||||||||||||||||||
|
Anti-dilutive shares
(1)
|
|
|
|
|
|||||||||||||||||||
|
Assets and Liabilities at Fair Value as of August 2, 2025
|
|||||||||||||||||||||||
| (in thousands) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
| Assets: | |||||||||||||||||||||||
|
Cash equivalents
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Derivative instruments
(2)
|
|
|
|
|
|||||||||||||||||||
|
Rabbi Trust assets
(3)
|
|
|
|
|
|||||||||||||||||||
|
Restricted cash equivalents
(1)
|
|
|
|
|
|||||||||||||||||||
| Total assets | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Liabilities: | |||||||||||||||||||||||
|
Derivative instruments
(2)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Total liabilities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Assets and Liabilities at Fair Value as of February 1, 2025
|
|||||||||||||||||||||||
| (in thousands) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
| Assets: | |||||||||||||||||||||||
|
Cash equivalents
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Derivative instruments
(2)
|
|
|
|
|
|||||||||||||||||||
|
Rabbi Trust assets
(3)
|
|
|
|
|
|||||||||||||||||||
|
Restricted cash equivalents
(1)
|
|
|
|
|
|||||||||||||||||||
| Total assets | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Abercrombie & Fitch Co. |
12
|
2025 2Q Form 10-Q
|
||||||
| (in thousands) | August 2, 2025 | February 1, 2025 | |||||||||
| Property and equipment, at cost | $ |
|
$ |
|
|||||||
| Less: Accumulated depreciation and amortization |
(
|
(
|
|||||||||
| Property and equipment, net | $ |
|
$ |
|
|||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | August 2, 2025 | August 3, 2024 | |||||||||||||||||||
|
Single lease cost
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Variable lease cost
(2)
|
|
|
|
|
|||||||||||||||||||
|
Operating lease right-of-use asset impairment
(3)
|
|
|
|
|
|||||||||||||||||||
|
Sublease income
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Total operating lease cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Abercrombie & Fitch Co. |
13
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | August 2, 2025 | August 3, 2024 | |||||||||||||||||||
| Operating lease right-of-use asset impairment | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Property and equipment asset impairment |
|
|
|
|
|||||||||||||||||||
|
Intangible asset impairment
|
|
|
|
|
|||||||||||||||||||
| Total asset impairment | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Abercrombie & Fitch Co. |
14
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | August 2, 2025 | August 3, 2024 | |||||||||||||||||||
| Share-based compensation expense | $ | 9,793 | $ | 9,233 | $ | 20,384 | $ | 20,596 | |||||||||||||||
|
Income tax benefits associated with share-based compensation expense recognized
|
|
|
|
|
|||||||||||||||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | August 2, 2025 | August 3, 2024 | |||||||||||||||||||||||||
|
Income tax discrete benefits realized for tax deductions related to the issuance of shares
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | August 2, 2025 | August 3, 2024 | |||||||||||||||||||
|
Employee tax withheld upon issuance of shares
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Abercrombie & Fitch Co. |
15
|
2025 2Q Form 10-Q
|
||||||
|
Service-based Restricted
Stock Units |
Performance-based Restricted
Stock Units |
Market-based Restricted
Stock Units |
|||||||||||||||||||||||||||||||||
|
Number of
Underlying Shares |
Weighted-
Average Grant Date Fair Value |
Number of
Underlying Shares |
Weighted-
Average Grant Date Fair Value |
Number of
Underlying Shares |
Weighted-
Average Grant Date Fair Value |
||||||||||||||||||||||||||||||
| Unvested at February 1, 2025 |
|
$ |
|
|
$ |
|
|
$ |
|
||||||||||||||||||||||||||
| Granted |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
|
Adjustments for performance achievement
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Vested |
(
|
|
(
|
|
(
|
|
|||||||||||||||||||||||||||||
| Forfeited |
(
|
|
(
|
|
(
|
|
|||||||||||||||||||||||||||||
|
Unvested at August 2, 2025
(1)
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||||||||||||||||||||||
|
Service-based Restricted
Stock Units |
Performance-based Restricted
Stock Units |
Market-based Restricted
Stock Units |
|||||||||||||||
|
Unrecognized compensation cost
(in thousands)
|
$ |
|
$ |
|
$ |
|
|||||||||||
|
Remaining weighted-average period cost is expected to be recognized
(years)
|
|
|
|
||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | |||||||||
| Service-based restricted stock units: | |||||||||||
| Total grant date fair value of awards granted | $ |
|
$ |
|
|||||||
| Total grant date fair value of awards vested |
|
|
|||||||||
| Performance-based restricted stock units: | |||||||||||
| Total grant date fair value of awards granted |
|
|
|||||||||
| Total grant date fair value of awards vested |
|
|
|||||||||
| Market-based restricted stock units: | |||||||||||
| Total grant date fair value of awards granted |
|
|
|||||||||
| Total grant date fair value of awards vested |
|
|
|||||||||
| Twenty-Six Weeks Ended | |||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||
| Grant date market price | $ |
|
$ |
|
|||||||
| Fair value |
|
|
|||||||||
| Price volatility |
|
% |
|
% | |||||||
|
Expected term
(years)
|
|
|
|||||||||
| Risk-free interest rate |
|
% |
|
% | |||||||
| Dividend yield |
|
|
|||||||||
| Average volatility of peer companies |
|
|
|||||||||
| Average correlation coefficient of peer companies |
|
|
|||||||||
| Abercrombie & Fitch Co. |
16
|
2025 2Q Form 10-Q
|
||||||
| (in thousands) |
Notional Amount
(1)
|
||||
| Euro | $ |
|
|||
| British pound |
|
||||
| Canadian dollar |
|
||||
| (in thousands) |
Notional Amount
(1)
|
||||
| Euro |
|
||||
| (in thousands) | Location | August 2, 2025 | February 1, 2025 | Location | August 2, 2025 | February 1, 2025 | |||||||||||||||||||||||||||||
| Derivatives designated as cash flow hedging instruments |
Other current assets
|
$ |
|
$ |
|
Accrued expenses
|
$ |
|
$ |
|
|||||||||||||||||||||||||
|
Derivatives not designated as hedging instruments
|
Other current assets
|
|
|
Accrued expenses
|
|
|
|||||||||||||||||||||||||||||
|
Total
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | August 2, 2025 | August 3, 2024 | |||||||||||||||||||||||||
|
(Loss) gain recognized in AOCL
(1)
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||
|
(Loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization
(2)
|
(
|
|
(
|
|
|||||||||||||||||||||||||
| Abercrombie & Fitch Co. |
17
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | |||||||||||||||||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||
|
Gain (loss) recognized in other operating (income) loss, net
|
$ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
| Thirteen Weeks Ended August 2, 2025 | |||||||||||||||||
| (in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
| Beginning balance at May 3, 2025 | $ |
(
|
$ |
(
|
$ |
(
|
|||||||||||
| Other comprehensive income (loss) before reclassifications |
|
(
|
|
||||||||||||||
|
Reclassified loss from AOCL
(1)
|
|
|
|
||||||||||||||
| Tax effect |
|
(
|
(
|
||||||||||||||
| Other comprehensive income after reclassifications |
|
|
|
||||||||||||||
| Ending balance at August 2, 2025 | $ |
(
|
$ |
(
|
$ |
(
|
|||||||||||
| Twenty-Six Weeks Ended August 2, 2025 | |||||||||||||||||
| (in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
| Beginning balance at February 1, 2025 | $ |
(
|
$ |
|
$ |
(
|
|||||||||||
| Other comprehensive income (loss) before reclassifications |
|
(
|
|
||||||||||||||
|
Reclassified loss from AOCL
(1)
|
|
|
|
||||||||||||||
| Tax effect |
|
|
|
||||||||||||||
| Other comprehensive income (loss) after reclassifications |
|
(
|
|
||||||||||||||
| Ending balance at August 2, 2025 | $ |
(
|
$ |
(
|
$ |
(
|
|||||||||||
| Thirteen Weeks Ended August 3, 2024 | |||||||||||||||||
| (in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
| Beginning balance at May 4, 2024 | $ |
(
|
$ |
|
$ |
(
|
|||||||||||
| Other comprehensive income (loss) before reclassifications |
|
(
|
|
||||||||||||||
|
Reclassified gain from AOCL
(1)
|
|
(
|
(
|
||||||||||||||
| Tax effect |
|
(
|
(
|
||||||||||||||
| Other comprehensive income (loss) after reclassifications |
|
(
|
|
||||||||||||||
| Ending balance at August 3, 2024 | $ |
(
|
$ |
(
|
$ |
(
|
|||||||||||
| Twenty-Six Weeks Ended August 3, 2024 | |||||||||||||||||
| (in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
| Beginning balance at February 3, 2024 | $ |
(
|
$ |
|
$ |
(
|
|||||||||||
| Other comprehensive income before reclassifications |
|
|
|
||||||||||||||
|
Reclassified gain from AOCL
(1)
|
|
(
|
(
|
||||||||||||||
| Tax effect |
|
(
|
(
|
||||||||||||||
| Other comprehensive income (loss) after reclassifications |
|
(
|
|
||||||||||||||
| Ending balance at August 3, 2024 | $ |
(
|
$ |
(
|
$ |
(
|
|||||||||||
| Abercrombie & Fitch Co. |
18
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended August 2, 2025 | |||||||||||||||||||||||
|
(in thousands)
|
Americas
(1)
|
EMEA | APAC | Total | |||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Cost of sales, exclusive of depreciation and amortization |
|
|
|
|
|||||||||||||||||||
|
Store occupancy
(2)
|
|
|
|
|
|||||||||||||||||||
|
Fulfillment
(2)
|
|
|
|
|
|||||||||||||||||||
|
Other expense
(3)
|
|
|
|
|
|||||||||||||||||||
| Segment income (loss) | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Operating loss not attributed to segments: | |||||||||||||||||||||||
|
Corporate and other unallocated expenses
(4)
|
(
|
||||||||||||||||||||||
| Operating income | $ |
|
|||||||||||||||||||||
|
Interest income, net
|
(
|
||||||||||||||||||||||
|
Income before income taxes
|
$ |
|
|||||||||||||||||||||
| Depreciation and amortization | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Depreciation and amortization not attributed to segments |
|
||||||||||||||||||||||
| Total depreciation and amortization | $ |
|
|||||||||||||||||||||
| Capital expenditures | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Capital expenditures not attributed to segments |
|
||||||||||||||||||||||
| Total capital expenditures | $ |
|
|||||||||||||||||||||
| Abercrombie & Fitch Co. |
19
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended August 3, 2024 | |||||||||||||||||||||||
| (in thousands) |
Americas
(1)
|
EMEA | APAC | Total | |||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Cost of sales, exclusive of depreciation and amortization |
|
|
|
|
|||||||||||||||||||
|
Store occupancy
(2)
|
|
|
|
|
|||||||||||||||||||
|
Fulfillment
(2)
|
|
|
|
|
|||||||||||||||||||
|
Other expense
(3)
|
|
|
|
|
|||||||||||||||||||
| Segment income (loss) | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Operating loss not attributed to segments: | |||||||||||||||||||||||
|
Corporate and other unallocated expenses
(4)
|
(
|
||||||||||||||||||||||
| Operating income | $ |
|
|||||||||||||||||||||
|
Interest income, net
|
(
|
||||||||||||||||||||||
|
Income before income taxes
|
$ |
|
|||||||||||||||||||||
| Depreciation and amortization | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Depreciation and amortization not attributed to segments |
|
||||||||||||||||||||||
| Total depreciation and amortization | $ |
|
|||||||||||||||||||||
| Capital expenditures | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Capital expenditures not attributed to segments |
|
||||||||||||||||||||||
| Total capital expenditures | $ |
|
|||||||||||||||||||||
|
Twenty-Six Weeks Ended August 2, 2025
|
|||||||||||||||||||||||
|
(in thousands)
|
Americas
(1)
|
EMEA | APAC | Total | |||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Cost of sales, exclusive of depreciation and amortization |
|
|
|
|
|||||||||||||||||||
|
Store occupancy
(2)
|
|
|
|
|
|||||||||||||||||||
|
Fulfillment
(2)
|
|
|
|
|
|||||||||||||||||||
|
Other expense
(3)
|
|
|
|
|
|||||||||||||||||||
| Segment income (loss) | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Operating loss not attributed to segments: | |||||||||||||||||||||||
|
Corporate and other unallocated expenses
(4)
|
(
|
||||||||||||||||||||||
| Operating income | $ |
|
|||||||||||||||||||||
|
Interest income, net
|
(
|
||||||||||||||||||||||
|
Income before income taxes
|
$ |
|
|||||||||||||||||||||
| Depreciation and amortization | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Depreciation and amortization not attributed to segments |
|
||||||||||||||||||||||
| Total depreciation and amortization | $ |
|
|||||||||||||||||||||
| Capital expenditures | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Capital expenditures not attributed to segments |
|
||||||||||||||||||||||
| Total capital expenditures | $ |
|
|||||||||||||||||||||
| Abercrombie & Fitch Co. |
20
|
2025 2Q Form 10-Q
|
||||||
|
Twenty-Six Weeks Ended August 3, 2024
|
|||||||||||||||||||||||
| (in thousands) |
Americas
(1)
|
EMEA | APAC | Total | |||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Cost of sales, exclusive of depreciation and amortization |
|
|
|
|
|||||||||||||||||||
|
Store occupancy
(2)
|
|
|
|
|
|||||||||||||||||||
|
Fulfillment
(2)
|
|
|
|
|
|||||||||||||||||||
|
Other expense
(3)
|
|
|
|
|
|||||||||||||||||||
| Segment income (loss) | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Operating loss not attributed to segments: | |||||||||||||||||||||||
|
Corporate and other unallocated expenses
(4)
|
(
|
||||||||||||||||||||||
| Operating income | $ |
|
|||||||||||||||||||||
|
Interest income, net
|
(
|
||||||||||||||||||||||
|
Income before income taxes
|
$ |
|
|||||||||||||||||||||
| Depreciation and amortization | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Depreciation and amortization not attributed to segments |
|
||||||||||||||||||||||
| Total depreciation and amortization | $ |
|
|||||||||||||||||||||
| Capital expenditures | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Capital expenditures not attributed to segments |
|
||||||||||||||||||||||
| Total capital expenditures | $ |
|
|||||||||||||||||||||
| Assets | |||||||||||||||||
| (in thousands) | August 2, 2025 | February 1, 2025 | August 3, 2024 | ||||||||||||||
| Inventories | |||||||||||||||||
| Americas | $ |
|
$ |
|
$ |
|
|||||||||||
| EMEA |
|
|
|
||||||||||||||
| APAC |
|
|
|
||||||||||||||
| Total inventories | $ |
|
$ |
|
$ |
|
|||||||||||
|
Assets not attributed to segments
|
|
|
|
||||||||||||||
| Total assets | $ |
|
$ |
|
$ |
|
|||||||||||
| (in thousands) | August 2, 2025 | February 1, 2025 | August 3, 2024 | ||||||||||||||
|
Americas
(1) (2)
|
$ |
|
$ |
|
$ |
|
|||||||||||
|
EMEA
(3)
|
|
|
|
||||||||||||||
| APAC |
|
|
|
||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
|||||||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | August 2, 2025 | August 3, 2024 | |||||||||||||||||||
|
Abercrombie
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Hollister
|
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Abercrombie & Fitch Co. |
21
|
2025 2Q Form 10-Q
|
||||||
| Abercrombie & Fitch Co. |
22
|
2025 2Q Form 10-Q
|
||||||
| Abercrombie & Fitch Co. |
23
|
2025 2Q Form 10-Q
|
||||||
| Fiscal year | Year ended/ending | Number of weeks | ||||||||||||
| Fiscal 2024 | February 1, 2025 | 52 | ||||||||||||
| Fiscal 2025 | January 31, 2026 | 52 | ||||||||||||
| Fiscal 2026 | January 30, 2027 | 52 | ||||||||||||
| Abercrombie & Fitch Co. |
24
|
2025 2Q Form 10-Q
|
||||||
| Abercrombie & Fitch Co. |
25
|
2025 2Q Form 10-Q
|
||||||
| GAAP |
Non-GAAP
(1)
|
|||||||||||||||||||||||||
| Thirteen Weeks Ended |
August 2, 2025
|
August 3, 2024
|
August 2, 2025
|
August 3, 2024
|
||||||||||||||||||||||
|
Net sales
(in thousands)
|
$ | 1,208,560 | $ | 1,133,974 | ||||||||||||||||||||||
| Change in net sales | 7 | % | 21 | % | ||||||||||||||||||||||
|
Comparable sales
(2)
|
3 | % | 18 | % | ||||||||||||||||||||||
|
Operating income
(in thousands)
|
$ | 206,658 | $ | 175,625 | $ | 168,084 | ||||||||||||||||||||
|
Operating income margin
|
17.1 | % | 15.5 | % | 13.9 | % | ||||||||||||||||||||
|
Net income attributable to A&F
(in thousands)
|
$ | 141,383 | $ | 133,168 | $ | 112,758 | ||||||||||||||||||||
| Net income per share attributable to A&F | 2.91 | 2.50 | 2.32 | |||||||||||||||||||||||
| Twenty-Six Weeks Ended | ||||||||||||||||||||||||||
| Net sales | $ | 2,305,871 | $ | 2,154,704 | ||||||||||||||||||||||
| Change in net sales | 7 | % | 22 | % | ||||||||||||||||||||||
|
Comparable sales
(2)
|
4 | % | 19 | % | ||||||||||||||||||||||
| Operating income | $ | 308,191 | $ | 305,474 | $ | 269,617 | ||||||||||||||||||||
|
Operating income margin
|
13.4 | % | 14.2 | % | 11.7 | % | ||||||||||||||||||||
| Net income attributable to A&F | $ | 221,796 | $ | 247,018 | $ | 193,171 | ||||||||||||||||||||
| Net income per share attributable to A&F | 4.47 | 4.64 | 3.90 | |||||||||||||||||||||||
| (in thousands) | August 2, 2025 | February 1, 2025 | ||||||||||||
| Cash and equivalents | $ | 572,730 | $ | 772,727 | ||||||||||
| Marketable securities | 30,795 | 116,221 | ||||||||||||
| Inventories | 592,966 | 575,005 | ||||||||||||
| (in thousands) | August 2, 2025 | August 3, 2024 | ||||||||||||
| Net cash provided by operating activities | $ | 112,893 | $ | 260,119 | ||||||||||
| Net cash used for investing activities | (31,943) | (96,649) | ||||||||||||
| Net cash used for financing activities | (290,713) | (326,961) | ||||||||||||
| Abercrombie & Fitch Co. |
26
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| (in thousands, except ratios) | August 2, 2025 | August 3, 2024 | $ Change | % Change |
Comparable
Sales
(1
)
|
||||||||||||||||||||||||
| By segment: | |||||||||||||||||||||||||||||
| Americas | $ | 974,200 | $ | 901,224 | $ | 72,976 | 8 | % | 5 | % | |||||||||||||||||||
| EMEA | 197,210 | 199,682 | (2,472) | (1) | (5) | ||||||||||||||||||||||||
| APAC | 37,150 | 33,068 | 4,082 | 12 | 1 | ||||||||||||||||||||||||
| Total | $ | 1,208,560 | $ | 1,133,974 | $ | 74,586 | 7 | 3 | |||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| (in thousands, except ratios) | August 2, 2025 | August 3, 2024 | $ Change | % Change |
Comparable
Sales
(1)
|
||||||||||||||||||||||||
| By segment: | |||||||||||||||||||||||||||||
| Americas | $ | 1,849,004 | $ | 1,721,345 | $ | 127,659 | 7 | % | 5 | % | |||||||||||||||||||
| EMEA | 382,246 | 364,460 | 17,786 | 5 | 0 | ||||||||||||||||||||||||
| APAC | 74,621 | 68,899 | 5,722 | 8 | 2 | ||||||||||||||||||||||||
| Total | $ | 2,305,871 | $ | 2,154,704 | $ | 151,167 | 7 | 4 | |||||||||||||||||||||
| Abercrombie & Fitch Co. |
27
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| (in thousands, except ratios) | August 2, 2025 | August 3, 2024 | $ Change | % Change |
Comparable
Sales
(1)
|
||||||||||||||||||||||||
|
Abercrombie
|
$ | 551,868 | $ | 582,416 | $ | (30,548) | (5) | % | (11) | % | |||||||||||||||||||
|
Hollister
|
656,692 | 551,558 | 105,134 | 19 | 19 | ||||||||||||||||||||||||
| Total | $ | 1,208,560 | $ | 1,133,974 | $ | 74,586 | 7 | 3 | |||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| (in thousands, except ratios) | August 2, 2025 | August 3, 2024 | $ Change | % Change |
Comparable
Sales
(1)
|
||||||||||||||||||||||||
|
Abercrombie
|
$ | 1,099,815 | $ | 1,153,929 | $ | (54,114) | (5) | % | (10) | % | |||||||||||||||||||
|
Hollister
|
1,206,056 | 1,000,775 | 205,281 | 21 | 20 | ||||||||||||||||||||||||
| Total | $ | 2,305,871 | $ | 2,154,704 | $ | 151,167 | 7 | 4 | |||||||||||||||||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Cost of sales, exclusive of depreciation and amortization | $ | 451,590 | 37.4 | % | $ | 397,712 | 35.1 | % | 230 | ||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
| Cost of sales, exclusive of depreciation and amortization | $ | 868,723 | 37.7 | % | $ | 740,985 | 34.4 | % | 330 | ||||||||||||||||||||
| Abercrombie & Fitch Co. |
28
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Selling expense | $ | 375,356 | 31.1 | % | $ | 382,557 | 33.7 | % | (260) | ||||||||||||||||||||
|
Excluded item:
|
|||||||||||||||||||||||||||||
|
Litigation Settlement
(1)
|
42,874 | 3.5 | — | — | 350 | ||||||||||||||||||||||||
|
Adjusted non-GAAP selling expense
|
$ | 418,230 | 34.6 | $ | 382,557 | 33.7 | 90 | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
| Selling expense | $ | 775,293 | 33.6 | % | $ | 742,575 | 34.5 | % | (90) | ||||||||||||||||||||
|
Excluded item:
|
|||||||||||||||||||||||||||||
|
Litigation Settlement
(1)
|
42,874 | 1.9 | — | — | 190 | ||||||||||||||||||||||||
|
Adjusted non-GAAP selling expense
|
$ | 818,167 | 35.5 | $ | 742,575 | 34.5 | 100 | ||||||||||||||||||||||
| Abercrombie & Fitch Co. |
29
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
|
General and administrative expense
|
$ | 175,325 | 14.5 | % | $ | 178,147 | 15.7 | % | (120) | ||||||||||||||||||||
|
Excluded item:
|
|||||||||||||||||||||||||||||
|
Litigation Settlement
(1)
|
(4,300) | (0.4) | — | — | (40) | ||||||||||||||||||||||||
|
Adjusted non-GAAP general and administrative expense
|
$ | 171,025 | 14.2 | $ | 178,147 | 15.7 | (150) | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
|
General and administrative expense
|
$ | 350,250 | 15.2 | % | $ | 367,695 | 17.1 | % | (190) | ||||||||||||||||||||
|
Excluded item:
|
|||||||||||||||||||||||||||||
|
Litigation Settlement
(1)
|
(4,300) | (0.2) | — | — | (20) | ||||||||||||||||||||||||
|
Adjusted non-GAAP general and administrative expense
|
$ | 345,950 | 15.0 | $ | 367,695 | 17.1 | (210) | ||||||||||||||||||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Other operating income, net | $ | (369) | — | % | $ | (67) | — | % | — | ||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
| Other operating (loss) income, net | $ | 3,414 | 0.1 | % | $ | (2,025) | (0.1) | % | 20 | ||||||||||||||||||||
| Abercrombie & Fitch Co. |
30
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) |
% of Net sales
(1)
|
% of Net sales
(1)
|
BPS Change | ||||||||||||||||||||||||||
| Americas | $ | 319,829 | 32.8 | % | $ | 275,120 | 30.5 | % | 230 | ||||||||||||||||||||
| EMEA | 24,530 | 12.4 | 38,040 | 19.1 | (670) | ||||||||||||||||||||||||
| APAC | (5,967) | (16.1) | (3,245) | (9.8) | (630) | ||||||||||||||||||||||||
| Operating loss not attributed to segments | (131,734) | (134,290) | |||||||||||||||||||||||||||
| Operating income | $ | 206,658 | 17.1 | $ | 175,625 | 15.5 | 160 | ||||||||||||||||||||||
|
Excluded item:
|
|||||||||||||||||||||||||||||
|
Litigation Settlement
(2)
|
38,574 | 3.2 | — | — | 320 | ||||||||||||||||||||||||
|
Adjusted non-GAAP operating income
|
$ | 168,084 | 13.9 | $ | 175,625 | 15.5 | (160) | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) |
% of Net Sales
(1)
|
% of Net Sales
(1)
|
BPS Change | ||||||||||||||||||||||||||
| Americas | $ | 546,789 | 29.6 | % | $ | 527,467 | 30.6 | % | (100) | ||||||||||||||||||||
| EMEA | 40,564 | 10.6 | 62,541 | 17.2 | (660) | ||||||||||||||||||||||||
| APAC | (10,377) | (13.9) | (3,567) | (5.2) | (870) | ||||||||||||||||||||||||
| Operating loss not attributed to segments | (268,785) | (280,967) | |||||||||||||||||||||||||||
| Operating income | $ | 308,191 | 13.4 | $ | 305,474 | 14.2 | (80) | ||||||||||||||||||||||
|
Excluded item:
|
|||||||||||||||||||||||||||||
|
Litigation Settlement
(2)
|
38,574 | 1.7 | — | — | 170 | ||||||||||||||||||||||||
|
Adjusted non-GAAP operating income
|
$ | 269,617 | 11.7 | $ | 305,474 | 14.2 | (250) | ||||||||||||||||||||||
| Abercrombie & Fitch Co. |
31
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Interest expense | $ | 620 | 0.1 | % | $ | 5,189 | 0.5 | % | (40) | ||||||||||||||||||||
| Interest income | (3,094) | (0.3) | (10,392) | (1.0) | 70 | ||||||||||||||||||||||||
| Interest income, net | $ | (2,474) | (0.2) | $ | (5,203) | (0.5) | 30 | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
| Interest expense | $ | 1,281 | 0.1 | % | $ | 10,969 | 0.5 | % | (40) | ||||||||||||||||||||
| Interest income | (10,538) | (0.5) | (21,195) | (1.0) | 50 | ||||||||||||||||||||||||
| Interest income, net | $ | (9,257) | (0.4) | $ | (10,226) | (0.5) | 10 | ||||||||||||||||||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||
| (in thousands, except ratios) | Effective Tax Rate | Effective Tax Rate | |||||||||||||||||||||
| Income tax expense | $ | 65,744 | 31.4 | % | $ | 45,449 | 25.1 | % | |||||||||||||||
|
Excluded item:
|
|||||||||||||||||||||||
|
Tax effect of pre-tax excluded items
(1)
|
(9,949) | — | |||||||||||||||||||||
| Adjusted non-GAAP income tax expense | $ | 55,795 | 32.7 | $ | 45,449 | 25.1 | |||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||
| (in thousands, except ratios) | Effective Tax Rate | Effective Tax Rate | |||||||||||||||||||||
| Income tax expense | $ | 92,321 | 29.1 | % | $ | 65,243 | 20.7 | % | |||||||||||||||
|
Excluded item:
|
|||||||||||||||||||||||
|
Tax effect of pre-tax excluded items
(1)
|
(9,949) | — | |||||||||||||||||||||
| Adjusted non-GAAP income tax expense | $ | 82,372 | 29.5 | $ | 65,243 | 20.7 | |||||||||||||||||
| Abercrombie & Fitch Co. |
32
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Net income attributable to A&F | $ | 141,383 | 11.7 | % | $ | 133,168 | 11.7 | % | — | ||||||||||||||||||||
|
Excluded item, net of tax
(1)
|
(28,625) | (2.4) | — | — | (240) | ||||||||||||||||||||||||
|
Adjusted non-GAAP net income attributable to A&F
|
$ | 112,758 | 9.3 | $ | 133,168 | 11.7 | (240) | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
| Net income attributable to A&F | $ | 221,796 | 9.6 | % | $ | 247,018 | 11.5 | % | (190) | ||||||||||||||||||||
|
Excluded item, net of tax
(1)
|
(28,625) | (1.2) | — | 0.0 | (120) | ||||||||||||||||||||||||
|
Adjusted non-GAAP net income attributable to A&F
|
$ | 193,171 | 8.4 | $ | 247,018 | 11.5 | (310) | ||||||||||||||||||||||
| Thirteen Weeks Ended | |||||||||||||||||
| August 2, 2025 | August 3, 2024 | $ Change | |||||||||||||||
|
Net income per diluted share attributable to A&F
|
$ | 2.91 | $ | 2.50 | $ | 0.41 | |||||||||||
|
Excluded item, net of tax
(1) (2)
|
(0.59) | — | (0.59) | ||||||||||||||
|
Adjusted non-GAAP net income per diluted share attributable to A&F
|
2.32 | 2.50 | (0.18) | ||||||||||||||
| Impact from changes in foreign currency exchange rates | — | 0.03 | (0.03) | ||||||||||||||
|
Adjusted non-GAAP net income per diluted share attributable to A&F on a constant currency basis
(2)
|
$ | 2.32 | $ | 2.53 | $ | (0.21) | |||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||
| August 2, 2025 | August 3, 2024 | $ Change | |||||||||||||||
|
Net income per diluted share attributable to A&F
|
$ | 4.47 | $ | 4.64 | $ | (0.17) | |||||||||||
|
Excluded item, net of tax
(1) (2)
|
(0.58) | — | (0.58) | ||||||||||||||
|
Adjusted non-GAAP net income per diluted share attributable to A&F
|
$ | 3.90 | $ | 4.64 | $ | (0.74) | |||||||||||
| Impact from changes in foreign currency exchange rates | — | (0.04) | 0.04 | ||||||||||||||
|
Adjusted non-GAAP net income per diluted share attributable to A&F on a constant currency basis
(2)
|
$ | 3.90 | $ | 4.60 | $ | (0.70) | |||||||||||
| Abercrombie & Fitch Co. |
33
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Net income | $ | 143,388 | 11.9 | % | $ | 135,379 | 11.9 | % | — | ||||||||||||||||||||
| Income tax expense | 65,744 | 5.4 | 45,449 | 4.0 | 140 | ||||||||||||||||||||||||
| Interest (income) expense, net | (2,474) | (0.2) | (5,203) | (0.5) | 30 | ||||||||||||||||||||||||
| Depreciation and amortization | 37,424 | 3.1 | 39,355 | 3.6 | (50) | ||||||||||||||||||||||||
|
EBITDA
(1)
|
$ | 244,082 | 20.2 | $ | 214,980 | 19.0 | 120 | ||||||||||||||||||||||
|
Excluded item:
|
|||||||||||||||||||||||||||||
|
Litigation Settlement
(2)
|
(38,574) | (3.2) | — | — | (320) | ||||||||||||||||||||||||
|
Adjusted EBITDA
(1)
|
$ | 205,508 | 17.0 | $ | 214,980 | 19.0 | (200) | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Net income | $ | 225,127 | 9.8 | % | $ | 250,457 | 11.6 | % | (180) | ||||||||||||||||||||
| Income tax expense | 92,321 | 4.0 | 65,243 | 3.0 | 100 | ||||||||||||||||||||||||
| Interest (income) expense, net | (9,257) | (0.4) | (10,226) | (0.5) | 10 | ||||||||||||||||||||||||
| Depreciation and amortization | 76,000 | 3.3 | 77,044 | 3.7 | (40) | ||||||||||||||||||||||||
|
EBITDA
(1)
|
$ | 384,191 | 16.7 | $ | 382,518 | 17.8 | (110) | ||||||||||||||||||||||
|
Excluded item:
|
|||||||||||||||||||||||||||||
|
Litigation Settlement
(2)
|
(38,574) | (1.7) | — | 0.0 | (170) | ||||||||||||||||||||||||
|
Adjusted EBITDA
(1)
|
$ | 345,617 | 15.0 | $ | 382,518 | 17.8 | (280) | ||||||||||||||||||||||
| Abercrombie & Fitch Co. |
34
|
2025 2Q Form 10-Q
|
||||||
| Abercrombie & Fitch Co. |
35
|
2025 2Q Form 10-Q
|
||||||
| (in thousands) | August 2, 2025 | ||||
| Loan cap | $ | 500,000 | |||
| Less: Outstanding stand-by letters of credit | (452) | ||||
| Borrowing capacity | 499,548 | ||||
|
Less: Minimum excess availability
(1)
|
(50,000) | ||||
| Borrowing capacity available | $ | 449,548 | |||
| Twenty-Six Weeks Ended | |||||||||||
| August 2, 2025 | August 3, 2024 | ||||||||||
| (in thousands) | |||||||||||
| Cash and equivalents, and restricted cash and equivalents, beginning of period | $ | 780,395 | $ | 909,685 | |||||||
| Net cash provided by operating activities | 112,893 | 260,119 | |||||||||
| Net cash used for investing activities | (31,943) | (96,649) | |||||||||
| Net cash used for financing activities | (290,713) | (326,961) | |||||||||
| Effect of foreign currency exchange rates on cash | 9,700 | 101 | |||||||||
| Net decrease in cash and equivalents, and restricted cash and equivalents | (200,063) | (163,390) | |||||||||
| Cash and equivalents, and restricted cash and equivalents, end of period | $ | 580,332 | $ | 746,295 | |||||||
| Abercrombie & Fitch Co. |
36
|
2025 2Q Form 10-Q
|
||||||
| Abercrombie & Fitch Co. |
37
|
2025 2Q Form 10-Q
|
||||||
|
Financial measures
(1)
|
Excluded items | |||||||
| Selling expense |
Settlement of claims to resolve payment card interchange fee litigation
|
|||||||
| General and administrative expense |
Legal fees in connection with settlement of claims to resolve payment card interchange fee litigation
|
|||||||
| Operating income |
Settlement, net of legal fees, of claims to resolve payment card interchange fee litigation
|
|||||||
|
Income tax expense
(2)
|
Tax effect of pre-tax excluded item
|
|||||||
|
Net income and net income per share attributable to A&F
(2)
|
Pre-tax excluded items and the tax effect of pre-tax excluded item
|
|||||||
|
(in thousands, except change in net sales, operating income margin and per share data)
|
Thirteen Weeks Ended | Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||||||
| Net sales | August 2, 2025 | August 3, 2024 | % Change | August 2, 2025 | August 3, 2024 | % Change | |||||||||||||||||||||||||||||
| GAAP | $ | 1,208,560 | $ | 1,133,974 | 7 | % | $ | 2,305,871 | $ | 2,154,704 | 7 | % | |||||||||||||||||||||||
| Impact from changes in foreign currency exchange rates | — | 10,707 | (1) | — | 10,499 | — | |||||||||||||||||||||||||||||
| Non-GAAP on a constant currency basis | $ | 1,208,560 | $ | 1,144,681 | 6 | % | $ | 2,305,871 | $ | 2,165,203 | 6 | % | |||||||||||||||||||||||
| Operating income | August 2, 2025 | August 3, 2024 |
BPS Change
(1)
|
August 2, 2025 | August 3, 2024 |
BPS Change
(1)
|
|||||||||||||||||||||||||||||
| GAAP | $ | 206,658 | $ | 175,625 | 160 | $ | 308,191 | $ | 305,474 | (80) | |||||||||||||||||||||||||
|
Excluded items
(2)
|
38,574 | — | 320 | 38,574 | — | 170 | |||||||||||||||||||||||||||||
| Adjusted non-GAAP | $ | 168,084 | $ | 175,625 | (160) | $ | 269,617 | $ | 305,474 | (250) | |||||||||||||||||||||||||
| Impact from changes in foreign currency exchange rates | — | 2,272 | 0 | — | (2,962) | 20 | |||||||||||||||||||||||||||||
| Adjusted non-GAAP on a constant currency basis | $ | 168,084 | $ | 177,897 | (160) | $ | 269,617 | $ | 302,512 | (230) | |||||||||||||||||||||||||
| Net income per share attributable to A&F | August 2, 2025 | August 3, 2024 | $ Change | August 2, 2025 | August 3, 2024 | $ Change | |||||||||||||||||||||||||||||
| GAAP | $ | 2.91 | $ | 2.50 | $ | 0.41 | $ | 4.47 | $ | 4.64 | $ | (0.17) | |||||||||||||||||||||||
|
Excluded items, net of tax
(2)
|
0.59 | — | 0.59 | 0.58 | — | 0.58 | |||||||||||||||||||||||||||||
| Adjusted non-GAAP | $ | 2.32 | $ | 2.50 | $ | (0.18) | $ | 3.90 | $ | 4.64 | $ | (0.74) | |||||||||||||||||||||||
| Impact from changes in foreign currency exchange rates | — | 0.03 | (0.03) | — | (0.04) | 0.04 | |||||||||||||||||||||||||||||
| Adjusted non-GAAP on a constant currency basis | $ | 2.32 | $ | 2.53 | $ | (0.21) | $ | 3.90 | $ | 4.60 | $ | (0.70) | |||||||||||||||||||||||
| Abercrombie & Fitch Co. |
38
|
2025 2Q Form 10-Q
|
||||||
| Thirteen Weeks Ended | ||||||||||||||||||||
| (in thousands, except ratios) | August 2, 2025 |
% of
Net Sales |
August 3, 2024 |
% of
Net Sales |
||||||||||||||||
| Net income | $ | 143,388 | 11.9 | % | $ | 135,379 | 11.9 | % | ||||||||||||
| Income tax expense | 65,744 | 5.4 | 45,449 | 4.0 | ||||||||||||||||
|
Interest income, net
|
(2,474) | (0.2) | (5,203) | (0.5) | ||||||||||||||||
| Depreciation and amortization | 37,424 | 3.1 | 39,355 | 3.6 | ||||||||||||||||
|
EBITDA
(1)
|
$ | 244,082 | 20.2 | $ | 214,980 | 19.0 | ||||||||||||||
| Adjustments to EBITDA | ||||||||||||||||||||
|
Litigation Settlement
(2)
|
(38,574) | (3.2) | — | — | ||||||||||||||||
|
Adjusted EBITDA
(1)
|
$ | 205,508 | 17.0 | $ | 214,980 | 19.0 | ||||||||||||||
| Twenty-Six Weeks Ended | ||||||||||||||||||||
| (in thousands, except ratios) | August 2, 2025 |
% of
Net Sales |
August 3, 2024 |
% of
Net Sales |
||||||||||||||||
| Net income | $ | 225,127 | 9.8 | % | $ | 250,457 | 11.6 | % | ||||||||||||
| Income tax expense | 92,321 | 4.0 | 65,243 | 3.0 | ||||||||||||||||
| Interest (income) expense, net | (9,257) | (0.4) | (10,226) | (0.5) | ||||||||||||||||
| Depreciation and amortization | 76,000 | 3.3 | 77,044 | 3.7 | ||||||||||||||||
|
EBITDA
(1)
|
$ | 384,191 | 16.7 | $ | 382,518 | 17.8 | ||||||||||||||
| Adjustments to EBITDA | ||||||||||||||||||||
|
Litigation settlement
(2)
|
(38,574) | (1.7) | — | — | ||||||||||||||||
|
Adjusted EBITDA
(1)
|
$ | 345,617 | 15.0 | $ | 382,518 | 17.8 | ||||||||||||||
| Abercrombie & Fitch Co. |
39
|
2025 2Q Form 10-Q
|
||||||
| Abercrombie & Fitch Co. |
40
|
2025 2Q Form 10-Q
|
||||||
| Abercrombie & Fitch Co. |
41
|
2025 2Q Form 10-Q
|
||||||
| Period (fiscal month) |
Total Number of Shares Purchased
(1)
|
Average Price Paid per Share
(4)
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(2)
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
(2)(3)(4)
|
|||||||||||||||||||
| May 4, 2025 through May 31, 2025 | 417 | $ | 79.35 | — | $ | 1,100,039,825 | |||||||||||||||||
| June 1, 2025 through July 5, 2025 | 382,129 | 79.93 | 374,414 | 1,070,079,572 | |||||||||||||||||||
| July 6, 2025 through August 2, 2025 | 226,714 | 89.05 | 224,980 | 1,050,048,833 | |||||||||||||||||||
| Total | 609,260 | 83.33 | 599,394 | 1,050,048,833 | |||||||||||||||||||
| Abercrombie & Fitch Co. |
42
|
2025 2Q Form 10-Q
|
||||||
| Exhibit | Document | |||||||
| 3.1 | ||||||||
| 3.2 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its Inline XBRL tags are embedded within the Inline XBRL document.* | |||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document.* | |||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.* | |||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.* | |||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.* | |||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.* | |||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101).* | |||||||
| Abercrombie & Fitch Co. |
43
|
2025 2Q Form 10-Q
|
||||||
| Abercrombie & Fitch Co. | ||||||||
|
Date: September 5, 2025
|
By: |
/s/ Robert J. Ball
|
||||||
|
Robert J. Ball
|
||||||||
|
Senior Vice President, Chief Financial Officer
(Principal Financial Officer and Authorized Officer)
|
||||||||
|
By:
|
/s/ Joseph Frericks
|
|||||||
|
Joseph Frericks
|
||||||||
|
Senior Vice President, Corporate Controller
(Principal Accounting Officer)
|
||||||||
| Abercrombie & Fitch Co. |
44
|
2025 2Q Form 10-Q
|
||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Target Corporation | TGT |
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|